Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial.
第一作者:
Kohei,Shitara
第一单位:
National Cancer Center Hospital East, Kashiwa, Japan. kshitara@east.ncc.go.jp.;Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan. kshitara@east.ncc.go.jp.
作者:
主题词
人类(Humans);胃肿瘤(Stomach Neoplasms);喜树碱(Camptothecin);女(雌)性(Female);基因扩增(Gene Amplification);男(雄)性(Male);受体, 成纤维细胞生长因子, 2型(Receptor, Fibroblast Growth Factor, Type 2);免疫轭合物(Immunoconjugates);中年人(Middle Aged);老年人(Aged);原癌基因蛋白质c-met(Proto-Oncogene Proteins c-met)
DOI
10.1038/s41591-024-02992-x
PMID
38745009
发布时间
2024-12-06
- 浏览0

Nature medicine
1933-1942页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文